NUR 465 Exam 1 Questions And Correct
Answers
Pharmacologic cClass c- cCORRECT cANS✔✔How cthe cdrug cworks c@ cmolecular,
ctissue cor cbody csystem clevel
ex c= c"vasodilator" cmakes cblood cvessels cwider c-- c"vaso-" crefers cto cblood cvessels
cwhich care ctissues
Med cAdministration cTL c- cCORRECT cANS✔✔1) c1906 cPure cFood c& cDrug cAct:
cProhibits cdrugs cwhich care cmisbranded cor cadulterated
2) c1912: cCannot cmake cfalse cclaims
3) c1938: cDrugs chave cto cbe ctested
4) c1975: cOne cstandardized cpublication cso ceveryone cis cworking cwith cthe csame
cinformation
5) c1994: cClear clabeling cof cdietary csupplements
6) c2002: cWorking con csafety cand cefficacy cfor cpediatric cdrugs
Preclinical cTesting c- cCORRECT cANS✔✔Performed c@ ccellular clevel cof canimals cto
clook cfor crisks cin chumans
Toxicities
Pharmacokinetic cproperties
Potentially cuseful cbiologic ceffects
Takes c1-5 cyrs cthen ccan ctrial cdrug con chumans
Stage c2 cof cTesting c(clinical cphase) c- cCORRECT cANS✔✔*Phase c1:* cTesting con
cvolunteers cto cdetermine cdosing
*Phase c2:* cIdentify clarge cgroups cof cpeople cto creceive cthe cdrug
*Phase c3:* cInvestigators caddress cconcerns
, c- cWas cthe cdrug ceffective?
c- cDoes cthe cdrug cmake cother cmedical cconditions cworse?
c- cDoes cthe cdrug cinteract cwith cother cmedications?
c- cDoes cthe cdrug ceffect call cof cthe cpeople cin cthe csame cway cor care cthere
cdifferences, csuch cas cmen cvs. cwomen?
Stage c3 cof ctesting- cNew cdrug capplication creview c- cCORRECT cANS✔✔Trade cname
cfinalized c& ctrials ccontinue con canimals/people
Stage c4 cof ctesting c- cPost-marketing csurveillance c- cCORRECT cANS✔✔clinical
ctrials/nda cis ccompleted
Goal c= cgive cdrug cto creg. cpop.
Clinical cTesting cw/o chuman cor canimal csubjects? c- cCORRECT cANS✔✔by cusing ca
csilicon cchip cthat cholds cblood/tissue c& cnew cdrug c--> cmimics cresponse cof ca clive
csubject
Drug cSchedules c- cCORRECT cANS✔✔
RN cResponsibilities c- cCORRECT cANS✔✔- cKnow cwhen ca cdrug cis cindicated
- cKnow cwhen ca cdrug cis cappropriate
- cKnow cwhen can cadverse cevent chas coccurred
- cKnow cwhat cto cdo cwhen csomething cgoes cwrong
- cUtilize cthe cavailable cresources cto censure csafe cnursing cpractice
Core cPt cVariables/Core cDrug cKnowledge c- cCORRECT cANS✔✔- cFactors cthat care
cunique cto ceach cperson
- cFactors cthat care cunique cto ca cdrug
- cNot ceveryone cresponds cthe csame cway
- cNot call cresponses ccan cbe canticipated
- cCPV's c(i.e cliver cdisease, cgenetic cdiseases, cenvironment, clifestyle/diet, cculture,
cetc.)
Allergic creaction c- cCORRECT cANS✔✔Acquired chyper cresponse cof cbody
Signs c= crash, cedema, crunny cnose, cred ceyes, canaphylaxis
*Adverse cevents* c- cCORRECT cANS✔✔undesired cevent cresults cfrom ctaking cmeds
ccorrectly
Type cA: cpredictable/dose cdependent c& ccan cbe cmild/mod/severe
Type cB:
Unpredictable, cNOT cdose crelated c& cinfluenced cby ccore cpt cvariables. cEffects
creduced cby clowering cdose/stopping cmed
Answers
Pharmacologic cClass c- cCORRECT cANS✔✔How cthe cdrug cworks c@ cmolecular,
ctissue cor cbody csystem clevel
ex c= c"vasodilator" cmakes cblood cvessels cwider c-- c"vaso-" crefers cto cblood cvessels
cwhich care ctissues
Med cAdministration cTL c- cCORRECT cANS✔✔1) c1906 cPure cFood c& cDrug cAct:
cProhibits cdrugs cwhich care cmisbranded cor cadulterated
2) c1912: cCannot cmake cfalse cclaims
3) c1938: cDrugs chave cto cbe ctested
4) c1975: cOne cstandardized cpublication cso ceveryone cis cworking cwith cthe csame
cinformation
5) c1994: cClear clabeling cof cdietary csupplements
6) c2002: cWorking con csafety cand cefficacy cfor cpediatric cdrugs
Preclinical cTesting c- cCORRECT cANS✔✔Performed c@ ccellular clevel cof canimals cto
clook cfor crisks cin chumans
Toxicities
Pharmacokinetic cproperties
Potentially cuseful cbiologic ceffects
Takes c1-5 cyrs cthen ccan ctrial cdrug con chumans
Stage c2 cof cTesting c(clinical cphase) c- cCORRECT cANS✔✔*Phase c1:* cTesting con
cvolunteers cto cdetermine cdosing
*Phase c2:* cIdentify clarge cgroups cof cpeople cto creceive cthe cdrug
*Phase c3:* cInvestigators caddress cconcerns
, c- cWas cthe cdrug ceffective?
c- cDoes cthe cdrug cmake cother cmedical cconditions cworse?
c- cDoes cthe cdrug cinteract cwith cother cmedications?
c- cDoes cthe cdrug ceffect call cof cthe cpeople cin cthe csame cway cor care cthere
cdifferences, csuch cas cmen cvs. cwomen?
Stage c3 cof ctesting- cNew cdrug capplication creview c- cCORRECT cANS✔✔Trade cname
cfinalized c& ctrials ccontinue con canimals/people
Stage c4 cof ctesting c- cPost-marketing csurveillance c- cCORRECT cANS✔✔clinical
ctrials/nda cis ccompleted
Goal c= cgive cdrug cto creg. cpop.
Clinical cTesting cw/o chuman cor canimal csubjects? c- cCORRECT cANS✔✔by cusing ca
csilicon cchip cthat cholds cblood/tissue c& cnew cdrug c--> cmimics cresponse cof ca clive
csubject
Drug cSchedules c- cCORRECT cANS✔✔
RN cResponsibilities c- cCORRECT cANS✔✔- cKnow cwhen ca cdrug cis cindicated
- cKnow cwhen ca cdrug cis cappropriate
- cKnow cwhen can cadverse cevent chas coccurred
- cKnow cwhat cto cdo cwhen csomething cgoes cwrong
- cUtilize cthe cavailable cresources cto censure csafe cnursing cpractice
Core cPt cVariables/Core cDrug cKnowledge c- cCORRECT cANS✔✔- cFactors cthat care
cunique cto ceach cperson
- cFactors cthat care cunique cto ca cdrug
- cNot ceveryone cresponds cthe csame cway
- cNot call cresponses ccan cbe canticipated
- cCPV's c(i.e cliver cdisease, cgenetic cdiseases, cenvironment, clifestyle/diet, cculture,
cetc.)
Allergic creaction c- cCORRECT cANS✔✔Acquired chyper cresponse cof cbody
Signs c= crash, cedema, crunny cnose, cred ceyes, canaphylaxis
*Adverse cevents* c- cCORRECT cANS✔✔undesired cevent cresults cfrom ctaking cmeds
ccorrectly
Type cA: cpredictable/dose cdependent c& ccan cbe cmild/mod/severe
Type cB:
Unpredictable, cNOT cdose crelated c& cinfluenced cby ccore cpt cvariables. cEffects
creduced cby clowering cdose/stopping cmed
